Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Arie Belldegrun

The Power List 2018 – Business Captains


Arie Belldegrun

Executive Chairman and Co-Founder, Allogene Therapeutics

Arie has founded several successful biopharmaceutical companies, including Agensys, Cougar Biotechnology, and most recently Kite pharma, acquired by Gilead in 2017 for $12 billion dollars. In October last year, Kite Pharma’s Yescarta became the second CAR-T therapy approved by the FDA. And in April, 2018, Arie raised $300 to co-found Allogene Therapeutics, which will acquire and advance a portfolio of off-the-shelf CAR-T therapies previously controlled by Pfizer.


Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register